Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 1
1988 1
1990 1
1993 2
1995 4
1996 2
1997 1
1998 3
1999 4
2001 1
2003 1
2004 1
2005 3
2006 4
2007 3
2008 3
2009 1
2010 10
2011 7
2012 19
2013 12
2014 7
2015 13
2016 6
2017 6
2018 4
2019 3
2020 1
2021 3
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Germline genetic contribution to the immune landscape of cancer.
Sayaman RW, Saad M, Thorsson V, Hu D, Hendrickx W, Roelands J, Porta-Pardo E, Mokrab Y, Farshidfar F, Kirchhoff T, Sweis RF, Bathe OF, Heimann C, Campbell MJ, Stretch C, Huntsman S, Graff RE, Syed N, Radvanyi L, Shelley S, Wolf D, Marincola FM, Ceccarelli M, Galon J, Ziv E, Bedognetti D. Sayaman RW, et al. Among authors: radvanyi l. Immunity. 2021 Feb 9;54(2):367-386.e8. doi: 10.1016/j.immuni.2021.01.011. Immunity. 2021. PMID: 33567262 Free PMC article.
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.
Peng W, Chen JQ, Liu C, Malu S, Creasy C, Tetzlaff MT, Xu C, McKenzie JA, Zhang C, Liang X, Williams LJ, Deng W, Chen G, Mbofung R, Lazar AJ, Torres-Cabala CA, Cooper ZA, Chen PL, Tieu TN, Spranger S, Yu X, Bernatchez C, Forget MA, Haymaker C, Amaria R, McQuade JL, Glitza IC, Cascone T, Li HS, Kwong LN, Heffernan TP, Hu J, Bassett RL Jr, Bosenberg MW, Woodman SE, Overwijk WW, Lizée G, Roszik J, Gajewski TF, Wargo JA, Gershenwald JE, Radvanyi L, Davies MA, Hwu P. Peng W, et al. Among authors: radvanyi l. Cancer Discov. 2016 Feb;6(2):202-16. doi: 10.1158/2159-8290.CD-15-0283. Epub 2015 Dec 8. Cancer Discov. 2016. PMID: 26645196 Free PMC article.
VISTA expression and patient selection for immune-based anticancer therapy.
Martin AS, Molloy M, Ugolkov A, von Roemeling RW, Noelle RJ, Lewis LD, Johnson M, Radvanyi L, Martell RE. Martin AS, et al. Among authors: radvanyi l. Front Immunol. 2023 Feb 20;14:1086102. doi: 10.3389/fimmu.2023.1086102. eCollection 2023. Front Immunol. 2023. PMID: 36891296 Free PMC article. Review.
Advances in the development of cancer immunotherapies.
Gao J, Bernatchez C, Sharma P, Radvanyi LG, Hwu P. Gao J, et al. Among authors: radvanyi lg. Trends Immunol. 2013 Feb;34(2):90-8. doi: 10.1016/j.it.2012.08.004. Epub 2012 Sep 30. Trends Immunol. 2013. PMID: 23031830 Free PMC article. Review.
Anti-carcinoembryonic antigen immunity.
DeBenedette M, Radvanyi L, Singh-Sandhu D, Berinstein NL. DeBenedette M, et al. Among authors: radvanyi l. Cancer Chemother Biol Response Modif. 2003;21:299-325. doi: 10.1016/s0921-4410(03)21015-2. Cancer Chemother Biol Response Modif. 2003. PMID: 15338752 Review. No abstract available.
The IL-2 cytokine family in cancer immunotherapy.
Sim GC, Radvanyi L. Sim GC, et al. Among authors: radvanyi l. Cytokine Growth Factor Rev. 2014 Aug;25(4):377-90. doi: 10.1016/j.cytogfr.2014.07.018. Epub 2014 Aug 1. Cytokine Growth Factor Rev. 2014. PMID: 25200249 Review.
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.
Bedognetti D, Ceccarelli M, Galluzzi L, Lu R, Palucka K, Samayoa J, Spranger S, Warren S, Wong KK, Ziv E, Chowell D, Coussens LM, De Carvalho DD, DeNardo DG, Galon J, Kaufman HL, Kirchhoff T, Lotze MT, Luke JJ, Minn AJ, Politi K, Shultz LD, Simon R, Thórsson V, Weidhaas JB, Ascierto ML, Ascierto PA, Barnes JM, Barsan V, Bommareddy PK, Bot A, Church SE, Ciliberto G, De Maria A, Draganov D, Ho WS, McGee HM, Monette A, Murphy JF, Nisticò P, Park W, Patel M, Quigley M, Radvanyi L, Raftopoulos H, Rudqvist NP, Snyder A, Sweis RF, Valpione S, Zappasodi R, Butterfield LH, Disis ML, Fox BA, Cesano A, Marincola FM; Society for Immunotherapy of Cancer (SITC) Cancer Immune Responsiveness Task Force and Working Groups. Bedognetti D, et al. Among authors: radvanyi l. J Immunother Cancer. 2019 May 22;7(1):131. doi: 10.1186/s40425-019-0602-4. J Immunother Cancer. 2019. PMID: 31113486 Free PMC article. Review.
118 results